Talking Points on Deprescribing in Hospice Care

 
Edition number: 1
Publisher: CRC Press
Date of Publication:
 
Normal price:

Publisher's listprice:
GBP 56.99
Estimated price in HUF:
27 526 HUF (26 215 HUF + 5% VAT)
Why estimated?
 
Your price:

24 773 (23 594 HUF + 5% VAT )
discount is: 10% (approx 2 753 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

 
  Piece(s)

 
 
 
 
Product details:

ISBN13:9781032491080
ISBN10:1032491086
Binding:Hardback
No. of pages:189 pages
Size:198x129 mm
Weight:510 g
Language:English
0
Category:
Short description:

Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications.

Long description:

Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications. It highlights the positive intervention of reducing polypharmacy, improving a terminally ill patient's quality of life, providing individual patient context and helping clinicians in deprescribing. It discusses good ethics, patient wishes and side effect protocols to discontinue no longer relevant medications, thus improving decision-making with the goal of enhancing the patient's quality of life during the time when it is needed the most.


Key Features:



  • Empowers the patient, their families, and the providers to have an open discussion about well-informed decision-making.

  • Equips the hospice and palliative care clinicians to comfortably explain the rationale and the discontinuation process of the unessential medications.

  • Highlights the most important facts in bullets along with a unique feature of providing ready-to-go conversational phrases.
Table of Contents:

  1. Introduction

  2. Physiologic changes of terminal illness

  3. Fundamentals of deprescribing

  4. Deprescribing Statins

  5. Deprescribing Benzodiazepines

  6. Deprescribing Antipsychotics

  7. Deprescribing SSRI and SNRIs

  8. Deprescribing Tricyclic Antidepressants

  9. Deprescribing Anticholinergic drugs for parkinsonism

  10. Deprescribing Anticholinergic drugs for urinary incontinence

  11. Deprescribing muscle relaxants

  12. Deprescribing long-term Opioids

  13. Deprescribing Proton Pump Inhibitors

  14. Deprescribing Allopurinol

  15. Deprescribing Antihyperglycemics Oral

  16. Deprescribing Antihyperglycemics Injectable

  17. Deprescribing anti-hypertensives

  18. Deprescribing Anticoagulants

  19. Deprescribing Cholinesterase inhibitors

  20. Deprescribing Glaucoma eye drops

  21. Deprescribing Vitamin D and Calcium

  22. Deprescribing NSAIDs

  23. Deprescribing gabapentin and pregabalin

  24. Deprescribing long-acting Beta agonist

  25. Deprescribing Vitamins

  26. Deprescribing medications in children

  27. Deprescribing in Transgender and LGBTQ

  28. Cultural competency in deprescribing

  29. Chaplain and medical social worker

  30. When to restart discontinued medications.

  31. Medicolegal aspects of deprescribing